FGF23 and atherosclerosis: Similarly, bone mineral disorders, altered fibroblast growth factor 23 (FGF23), low vitamin-D levels and hyperphosphatemia all impinge upon microvascular dysfunction, thereby triggering or worsening subclinical atherosclerosis [21].